tiprankstipranks
Rua Bioscience Ltd. (NZ:RUA)
:RUA
New Zealand Market
RUA
Rua Bioscience Ltd.
RESEARCH TOOLSreports
Want to see NZ:RUA full AI Analyst Report?

Rua Bioscience Ltd. (RUA) Ratios

― Followers

Rua Bioscience Ltd. Ratios

NZ:RUA's free cash flow for Q2 2026 was $-0.92. For the 2026 fiscal year, NZ:RUA's free cash flow was decreased by $ and operating cash flow was $-1.32. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 1.58 1.25 3.22 7.35 2.34
Quick Ratio
 1.33 1.03 2.91 7.33 2.30
Cash Ratio
 0.77 0.13 1.02 3.32 0.39
Solvency Ratio
 -1.15 -1.66 -13.69 -6.35 -0.83
Operating Cash Flow Ratio
 -0.81 -1.48 -4.11 -7.51 -1.39
Short-Term Operating Cash Flow Coverage
 -1.29 -4.14 0.00 0.00 -52.72
Net Current Asset Value
$ 1.60M$ 414.59K$ 1.84M$ 4.77M$ 2.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.11 0.02 <0.01 0.02
Debt-to-Equity Ratio
 0.32 0.15 0.02 <0.01 0.03
Debt-to-Capital Ratio
 0.24 0.13 0.02 <0.01 0.03
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.49 1.38 1.14 1.04 1.39
Debt Service Coverage Ratio
 -1.55 -3.58 -788.32 -275.44 -45.93
Interest Coverage Ratio
 -17.72 -20.60 -311.07 -644.26 -200.93
Debt to Market Cap
 0.23 0.14 0.00 0.00 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.10 -0.17 0.06 0.46 0.16
Profitability Margins
Gross Profit Margin
-30.32%48.60%-137.83%5.07%-21537.05%
EBIT Margin
-146.83%-171.68%-15962.67%-1660.56%-31306.49%
EBITDA Margin
-139.56%-153.85%-15496.88%-1469.05%-27361.34%
Operating Profit Margin
-215.68%-173.59%-6115.07%-3436.57%-33856.96%
Pretax Profit Margin
-150.26%-181.90%-15982.33%-1665.90%-30900.62%
Net Profit Margin
-147.03%-181.90%-15982.33%-1666.12%-35647.87%
Continuous Operations Profit Margin
-147.03%-181.90%-15982.33%-1666.12%-35647.87%
Net Income Per EBT
97.85%100.00%100.00%100.01%115.36%
EBT Per EBIT
69.67%104.79%261.36%48.48%91.27%
Return on Assets (ROA)
-39.61%-51.03%-177.25%-28.44%-25.72%
Return on Equity (ROE)
-64.21%-70.66%-202.74%-29.62%-35.69%
Return on Capital Employed (ROCE)
-86.04%-66.91%-76.45%-60.89%-28.56%
Return on Invested Capital (ROIC)
-64.61%-58.61%-75.91%-60.75%-28.31%
Return on Tangible Assets
-52.97%-75.50%-247.41%-58.33%-47.69%
Earnings Yield
-38.44%-71.43%-192.63%-29.75%-20.64%
Efficiency Ratios
Receivables Turnover
 6.30 5.32 0.31 0.41 0.02
Payables Turnover
 3.53 1.14 0.49 1.23 0.41
Inventory Turnover
 4.48 2.41 0.74 23.71 0.59
Fixed Asset Turnover
 1.18 0.86 0.03 0.08 <0.01
Asset Turnover
 0.27 0.28 0.01 0.02 <0.01
Working Capital Turnover Ratio
 2.25 1.59 0.03 0.06 <0.01
Cash Conversion Cycle
 35.95 -99.49 922.37 598.51 15.85K
Days of Sales Outstanding
 57.96 68.55 1.18K 880.66 16.13K
Days of Inventory Outstanding
 81.44 151.42 496.22 15.39 620.82
Days of Payables Outstanding
 103.46 319.46 750.06 297.55 900.64
Operating Cycle
 139.41 219.97 1.67K 896.06 16.75K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.02 -0.02 -0.04 -0.05
Free Cash Flow Per Share
 >-0.01 -0.02 -0.02 -0.04 -0.05
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.34 1.00 1.00 1.01 1.06
Dividend Paid and CapEx Coverage Ratio
 -1.51 -792.72 -2.97K -77.64 -16.94
Capital Expenditure Coverage Ratio
 -1.51 -792.72 -2.97K -77.64 -16.94
Operating Cash Flow Coverage Ratio
 -1.25 -3.70 -24.33 -49.99 -8.22
Operating Cash Flow to Sales Ratio
 -0.98 -1.43 -41.89 -16.01 -279.71
Free Cash Flow Yield
-9.77%-56.27%-50.51%-28.96%-17.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.60 -1.40 -0.52 -3.36 -4.85
Price-to-Sales (P/S) Ratio
 3.40 2.55 82.97 56.01 1.73K
Price-to-Book (P/B) Ratio
 1.53 0.99 1.05 1.00 1.73
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.23 -1.78 -1.98 -3.45 -5.83
Price-to-Operating Cash Flow Ratio
 -3.90 -1.78 -1.98 -3.50 -6.18
Price-to-Earnings Growth (PEG) Ratio
 -0.04 0.02 >-0.01 0.10 -0.07
Price-to-Fair Value
 1.53 0.99 1.05 1.00 1.73
Enterprise Value Multiple
 -2.34 -1.82 -0.48 -3.35 -6.15
Enterprise Value
 7.65M 5.33M 6.37M 17.62M 40.78M
EV to EBITDA
 -2.34 -1.82 -0.48 -3.35 -6.15
EV to Sales
 3.26 2.81 74.26 49.26 1.68K
EV to Free Cash Flow
 -9.82 -1.96 -1.77 -3.04 -5.68
EV to Operating Cash Flow
 -3.33 -1.96 -1.77 -3.08 -6.02
Tangible Book Value Per Share
 0.01 0.02 0.02 0.06 0.06
Shareholders’ Equity Per Share
 0.02 0.03 0.04 0.13 0.16
Tax and Other Ratios
Effective Tax Rate
 0.02 0.00 0.00 >-0.01 -0.15
Revenue Per Share
 <0.01 0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.01 -0.02 -0.07 -0.04 -0.06
Tax Burden
 0.98 1.00 1.00 1.00 1.15
Interest Burden
 1.02 1.06 1.00 1.00 0.99
Research & Development to Revenue
 0.42 0.50 13.70 4.44 122.91
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.02 0.00 0.25 -5.75
Income Quality
 0.67 0.79 0.26 0.96 0.78
Currency in NZD